Search
for
Sort by
Research 301–330 of 1000+
- Pharmacotherapy of polycystic ovary syndrome - an update
- Shedding: How to manage a common cause of hair loss
- Quantitative Models for the Study of Hair Growth <i>in Vivo</i><sup>a</sup>
- In vitro bioassays for androgens and their diagnostic applications
- The control of hair growth.
- Hair Biology
- What every physician should know about polycystic ovary syndrome
- Gender-Affirming Hormone Therapy for Transgender Females
- Understanding and Addressing Hair Disorders in Transgender Individuals
- A Clinical Approach to Severe Insulin Resistance
- Cardiovascular risk factors and events in women with androgen excess
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Base and Clinical Experience
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Polycystic ovary syndrome: A review for dermatologists
- Understanding and Management of Female Pattern Alopecia
- Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach
- Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review includingGRADEassessments
- Treatment of female pattern hair loss with the androgen receptor antagonist flutamide
- Endocrine evaluation of hirsutism
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Management of Hair Loss in Women
- Incidence of Increased Androgen Levels in Patients Suffering from Acne
- PCOS in Adolescence and Type 2 Diabetes
- The mRNA for Protease Nexin-1 is Expressed in Human Dermal Papilla Cells and its Level is Affected by Androgen
- Androgen antagonists in androgen target tissues
- Flutamide in the treatment of hirsutism
- RU 58841-myristate–prodrug development for topical treatment of acne and androgenetic alopecia.
- Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy
- Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone